A popular heartburn medicine is being pulled off shelves worldwide due to cancer fears.
Zantac 150mg/10ml Syrup, Zantac 50mg/2ml Injection, Zantac 150mg Tablets and Zantac 300mg Tablets are being recalled in all markets after the US Food and Drug Administration found they may contain an impurity that has been linked to cancer.
Pharmacy chains in America, the UK and Europe have also started suspending the sale of a generic version of the drug called Ranitidine.
Healthcare professionals overseas have been told to stop supplying the products immediately, quarantine all remaining stock and return it to their supplier.
Those who have been prescribed the medication in Australia are encouraged to visit their GP.